Hepatic Cell News Volume 5.19 | May 28 2021

    0
    27








    Subject


    Hepatic Cell News by STEMCELL Technologies
    Vol. 5.19 – 28 May, 2021
    TOP STORY

    The Zinc Finger Protein Miz1 Suppresses Liver Tumorigenesis by Restricting Hepatocyte-Driven Macrophage Activation and Inflammation

    Researchers reported that the zinc finger transcription factor Miz1 restricted hepatocyte-driven inflammation to suppress hepatocellular carcinoma, independently of its transcriptional activity.
    [Immunity]

    Abstract

    Explore scientific events this June with the Science Events Calendar.
    PUBLICATIONSRanked by the impact factor of the journal

    Exosomal S100A4 Derived from Highly Metastatic Hepatocellular Carcinoma Cells Promotes Metastasis by Activating STAT3

    The metastatic effects of exosomes derived from highly metastatic hepatocellular carcinoma cells were evaluated both in vitro and in vivo.
    [Signal Transduction and Targeted Therapy]

    Full Article

    PPDPF Alleviates Hepatic Steatosis through Inhibition of mTOR Signaling

    Scientists found that liver-specific knockout of pancreatic progenitor cell differentiation and proliferation factor (PPDPF) led to spontaneous fatty liver formation in a mouse model at 32 weeks of age on chow diets, which was enhanced by HFD.
    [Nature Communications]

    Full Article

    Anti-miR-518d-5p Overcomes Liver Tumor Cell Death Resistance through Mitochondrial Activity

    In vitro and in vivo studies were performed in human hepatoma BCLC3 and Huh7 cells to analyze the effect of miR-518d-5p inhibition/overexpression during the response to sorafenib.
    [Cell Death & Disease]

    Full Article

    PNO1 Regulates Autophagy and Apoptosis of Hepatocellular Carcinoma via the MAPK Signaling Pathway

    Researchers explored the molecular mechanisms of PNO1 in hepatocellular carcinoma. Using 150 formalin-fixed and paraffin-embedded samples and 8 fresh samples, they found high PNO1 expression in hepatocellular carcinoma tumor tissues through Western blotting and RT-PCR.
    [Cell Death & Disease]

    Full Article

    Live-Cell ATR-FTIR Spectroscopy as a Novel Bioanalytical Tool for Cell Glucose Metabolism Research

    Live HepG2 cells were treated in normal glucose or high glucose medium and were measured directly using the FTIR approach.
    [Biochimica Et Biophysica Acta-Molecular Cell Research]

    Full Article

    Identification of Hepatic Fibrosis Inhibitors through Morphometry Analysis of a Hepatic Multicellular Spheroids Model

    Scientists established liver fibrosis models using multicellular tumor spheroids composed of hepatocellular carcinoma and stromal cells such as fibroblasts, hepatic stellate cells, and endothelial cells seeded at constant ratios.
    [Scientific Reports]

    Full Article

    Continual Proteomic Divergence of HepG2 Cells as a Consequence of Long-Term Spheroid Culture

    Researchers assessed the influence of culture duration on the relative proteome abundance of HepG2 cells cultured as spheroids, which are routinely used to model aspects of the liver.
    [Scientific Reports]

    Full Article

    Identification of BHLHE40 Expression in Peripheral Blood Mononuclear Cells as a Novel Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma

    Scientists investigated transcription profiles from peripheral blood mononuclear cells of 8 patients with hepatocellular carcinoma and PBMCs from co-culture model with hepatocellular carcinoma using RNA-Sequencing.
    [Scientific Reports]

    Full Article

    Genetic Effects on Liver Chromatin Accessibility Identify Disease Regulatory Variants

    Researchers mapped caQTLs in human liver tissue in 20 liver samples and identified 3,123 caQTLs.
    [The American Journal of Human Genetics]

    Abstract

    Learn more about HepatiCult Organoid Growth Medium (Mouse)
    REVIEWS

    Recent Advances in Bionanomaterials for Liver Cancer Diagnosis and Treatment

    The authors discuss the key advances in nanoparticles that have potential for liver cancer diagnosis and treatment. They also discuss the potential of nanoparticles to overcome the limitations of existing therapeutic modalities.
    [Biomaterials Science]

    Abstract

    Infections at the Nexus of Metabolic-Associated Fatty Liver Disease

    Investigator focus in particular on how infectious diseases, including coronavirus disease-19, hepatitis C, acquired immunodeficiency syndrome, peptic ulcer and periodontitis, exacerbate metabolic-associated fatty liver disease.
    [Archives of Toxicology]

    Full Article

    INDUSTRY AND POLICY NEWS

    Bavarian Nordic Announces Marketing and Distribution Agreement with Dynavax to Launch HEPLISAV B® Hepatitis B Vaccine in Germany

    Bavarian Nordic, Inc. has entered a partnership with Dynavax Technologies Corporation a biopharmaceutical company focused on developing and commercializing novel vaccines for the marketing and distribution of their HEPLISAV B® Hepatitis B vaccine in Germany with an expected launch in the fourth quarter of 2021.
    [Bavarian Nordic, Inc. (Globenews Wire, Inc.)]

    Press Release

    PCI Biotech Receives Orphan Drug Designation in South Korea for Fimaporfin in the Treatment of Bile Duct Cancer

    PCI Biotech, Inc. a cancer focused biopharmaceutical company announced that the Ministry of Food and Drug Safety in South Korea has granted Orphan Drug Designation to its lead product candidate, fimaporfin, for combination treatment with gemcitabine in patients with inoperable locally advanced or metastatic bile duct cancer.
    [PCI Biotech, Inc. (Globenews Wire, Inc.)]

    Press Release

    FEATURED EVENT

    Healthy Aging

    May 25 – 27, 2022
    Hinxton, England, United Kingdom

    > See All Events

    JOB OPPORTUNITIES

    Bioinformatician – Genomics

    Deep Genomics, Inc. – Toronto, Ontario, Canada

    Assistant Professor – Drug Metabolism, Liver Disease

    University of Pittsburgh – Pittsburgh, Pennsylvania, United States

    Postdoctoral Fellow – Fatty Liver and Diabetes

    Albert Einstein College of Medicine – Bronx, New York, United States

    Director – Liver Disease

    The Griffin Institute – Harrow, United Kingdom

    Senior Associate Scientist – Fibrosis Biology

    Gilead Sciences, Inc. – Foster City, California, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hepatic Cell News Twitter